Merali, Zahra <br/><br/>
The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.  [electronic resource] 

 -  Drug metabolism and drug interactions  2014 
 - 143-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>2191-0162 
<br/><br/><label>Standard No.: </label>10.1515/dmdi-2014-0009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin-Converting Enzyme Inhibitors--metabolism<br/>Antiviral Agents--metabolism<br/>Aspirin--metabolism<br/>Benzimidazoles--metabolism<br/>Camptothecin--analogs & derivatives<br/>Carboxylesterase--genetics<br/>Carboxylic Ester Hydrolases--chemistry<br/>Central Nervous System Stimulants--metabolism<br/>Clopidogrel<br/>Dabigatran<br/>Factor Xa Inhibitors--metabolism<br/>Genotype<br/>Humans<br/>Imidazolidines--metabolism<br/>Irinotecan<br/>Isoenzymes--chemistry<br/>Methylphenidate--metabolism<br/>Oseltamivir--metabolism<br/>Platelet Aggregation Inhibitors--metabolism<br/>Polymorphism, Genetic<br/>Pyridines--metabolism<br/>Ticlopidine--analogs & derivatives